University Hospital, Lille
ECMO has improved the outcome of heart or respiratory failure and carcinogenic shock and are increasingly used. However bleeding complications occurring in up to 50% of patients are poorly understood and worsen the overall results. The aim is to investigate the occurence of bleeding and its frequency according to the type of ECMO either veno-arterial or veno-venous. The investigators also want to assess the relation of bleeding with von Willebrand Factor defects.
Von Willebrand Diseases
Study Type : | OBSERVATIONAL |
Estimated Enrollment : | 418 participants |
Official Title : | Study of the Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients of a Veino Arterial or Veinous ECMO |
Actual Study Start Date : | 2018-01-19 |
Estimated Primary Completion Date : | 2026-05 |
Estimated Study Completion Date : | 2026-05 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
CH ARRAS
Arras, France,
RECRUITING
CH Boulogne
Boulogne-sur-Mer, France,
RECRUITING
Ch Douai
Douai, France,
RECRUITING
CH Dunkirk
Dunkirk, France, 59385
RECRUITING
Cardiology hospital, CHU
Lille, France,
RECRUITING
Ch Tourcoing
Tourcoing, France,
RECRUITING
Ch Valenciennes
Valenciennes, France,